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Abstract
Background: Acinetobacter baumannii has emerged as a significant nosocomial pathogen during the last few years,
exhibiting resistance to almost all major classes of antibiotics. Alternative treatment options such as vaccines tend
to be most promising and cost effective approaches against this resistant pathogen. In the current study, we have
explored the pan-genome of A. baumannii followed by immune-proteomics and reverse vaccinology approaches to
identify potential core vaccine targets.
Results: The pan-genome of all available A. baumannii strains (30 complete genomes) is estimated to contain 7,606
gene families and the core genome consists of 2,445 gene families (~32 % of the pan-genome). Phylogenetic tree,
comparative genomic and proteomic analysis revealed both intra- and inter genomic similarities and evolutionary
relationships. Among the conserved core genome, thirteen proteins, including P pilus assembly protein, pili
assembly chaperone, AdeK, PonA, OmpA, general secretion pathway protein D, FhuE receptor, Type VI secretion
system OmpA/MotB, TonB dependent siderophore receptor, general secretion pathway protein D, outer membrane
protein, peptidoglycan associated lipoprotein and peptidyl-prolyl cis-trans isomerase are identified as highly
antigenic. Epitope mapping of the target proteins revealed the presence of antigenic surface exposed 9-mer T-cell
epitopes. Protein-protein interaction and functional annotation have shown their involvement in significant
biological and molecular processes. The pipeline is validated by predicting already known immunogenic targets
against Gram negative pathogen Helicobacter pylori as a positive control.
Conclusion: The study, based upon combinatorial approach of pan-genomics, core genomics, proteomics and
reverse vaccinology led us to find out potential vaccine candidates against A. baumannii. The comprehensive
analysis of all the completely sequenced genomes revealed thirteen putative antigens which could elicit substantial
immune response. The integration of computational vaccinology strategies would facilitate in tackling the rapid
dissemination of resistant A.baumannii strains. The scarcity of effective antibiotics and the global expansion of
sequencing data making this approach desirable in the development of effective vaccines against A. baumannii and
other bacterial pathogens.
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Background
Acinetobacter baumannii is a Gram-negative coccobacil-
lus responsible for nosocomial outbreaks and healthcare
associated infections such as septicemia and pneumonia
in the immuno-compromised patients [1]. During the
last three decades, A. baumannii has emerged as one of
the most difficult super-bug to treat in hospitals, world-
wide [2]. It accounts for causing infections in about
12,000 patients annually and approximately 500 deaths
in the United States, only [3]. The alarming characteris-
tic of this pathogen is its ability to develop diverse
mechanisms of resistance to existing drugs ultimately
leading to therapeutic failures [4]. Recently, Infectious
Diseases Society of America (IDSA) has included A. bau-
mannii in the hit-list of top six priority pathogens, thus
requiring a prompt response by the healthcare commu-
nity to curb this pathogen [5, 6]. The massive challenge
posed by multi and pan-drug resistant A. baumannii in
the current post antibiotic era requires aggressive ex-
ploration of other solutions [7].
Besides active infection control measures and antibiotic
stewardship programs, vaccination approach is predomin-
antly reckoned as an alternative therapy to reduce the bur-
den of infections caused by this pathogen [8]. Nevertheless,
sequence- based reverse vaccinology approaches presented
a more rational methodology to vaccine design since the
discovery of universal vaccine against serogroup B menin-
gococcal (menB) disease in 2000 [9, 10]. These in silico
strategies led to comprehensive analysis of the pathogen
genomics, proteomics, essential molecular pathways, viru-
lence factors and host-pathogen interactions [11].
The global and rapid emergence of resistant A. bau-
mannii necessitates a comprehensive and integrated
study to find an alternative solution to this immediate
threat. Since A. baumannii strains share a relatively high
conserved features (genomic content) [12], therefore,
pan-genome analysis could be a suitable strategy to
analyze the available genomic data (genomes) of A. bau-
mannii to explore the possible conservations and gen-
omic diversity. In this study, we have analyzed all
available complete genome sequences of A. baumannii
strains and estimated the pan-genome with an aim to
identify potential conserved immunogenic targets. To
predict the promising broad spectrum vaccine candi-
dates, we have explored the conserved genome which
was subsequently analyzed for essential, virulent and
antigenic proteins lying within the exo-proteome or
secretome [13, 14]. Proteins substantiating to have a
potential for vaccine candidates were then subjected
to epitope mapping to predict the exposed antigenic
epitopes possessing the ability to bind with both
MHC I and II molecules. The schematic flowchart in
Fig. 1 illustrates the strategy followed in this study in-
corporating combinatorial computational approaches,
which could also provide an effective platform for
the identification of vaccine targets against other
pathogens.
Fig. 1 Schematic flow chart for the identification of putative core
vaccine candidates in Acinetobacter baumannii. Sequences retrieved
from NCBI were explored to get insight into the pan- and core
genome of the strains. The evolutionary relationship between strains
based on 16srRNA sequences was estimated. An elaborative inter-
and intra-proteome comparison was executed followed by pan-core
tree generation. Core proteome was subjected to reverse vaccinol-
ogy approaches (sub-cellular localization, molecular weight estima-
tion, essentiality, virulence, non-host homologs and trans-membrane
helices) in order to prioritize efficient vaccine targets against A. bau-
mannii. Subsequently, functional annotation of potential targets, the
surface topology of predicted epitopes and their interactions with
other proteins was determined
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Methods
Selection of genomes and genes predictions
To have a comprehensive overview of the species A.
baumannii, the study included all the available
completely sequenced genomes of A. baumannii
strains, till the writing of the manuscript. The drafts
and incomplete genomes were excluded to have
standardization in the analysis. Genbank files were re-
trieved from NCBI Genbank (http://www.ncbi.nlm.
nih.gov/genome) (NCBI Genome, RRID: SCR_002474).
The DNA sequences of both the chromosome and
plasmids in fasta format were retrieved and merged
for each genome. For the prediction of genes and
proteins the program Prodigal (Prokaryotic dynamic
programming gene finding algorithm) was used. Prod-
igal was considered for its additional features such as
increased sensitivity and specificity in gene prediction
with improved translation initiation site recognition
and reduced false positive predictions [15]. Table 1 il-
lustrates the genomic data including accession num-
bers of chromosomes and plasmids, genome size, GC
content and numbers of genes provided by NCBI and
the one predicted by Prodigal.
Genome organization and pathogenomics
To explore the genetic relatedness and evolutionary rela-
tionships, the selected strains were evaluated for their re-
spective clonal lineage through previously published
literature and phylogentic analysis [16, 17]. Clonal studies
play a vital role to get insight about epidemiology of iso-
lates and aid to control outbreaks both at the institutional
level and global level [18]. Drug resistant strains of A. bau-
mannii categorized as international clone (IC) I, II and III
resulted in devastating outbreaks at global level [19, 20].
According to publicly available Pasteur’s MLST scheme
(http://pubmlst.org/abaumannii/), IC II is considered
as the largest clone in the global population, followed
by I CI with distribution in more than 30 countries,
worldwide [21]. The included strains were analyzed
for the clonal distribution of virulence factors through
Virulence factor database (VFDB) RRID:SCR_007969
[22]. Acquisition of virulence factors supports the
bacteria to invade the host, evade the host defenses
and persist in the host environment [23, 24]. With
the aim to get insight into the virulence and patho-
genic potential of A. baumannii, the virulence factors
present in core genome were explored by employing
VFDB and MvirDB [22, 25].
Phylogenetic analysis
To better understand the evolutionary relationships and
genomic variations, the A. baumannii genomes were ana-
lyzed through phylogenetic tree. The 16SrRNA genes were
predicted by program RNAmmer [26]. Since 16SrRNA
gene exhibit slower rate of evolution and are considered
as hotspot for mutation, therefore frequently targeted for
estimation of phylogenetic relationships between bacterial
strains. Those sequences with reliable score of more than
1700 were considered for further evaluation [27]. Clus-
talW (RRID:SCR_002909) [28] was used for the multiple
alignment of 16SrRNA sequences. MEGA6 [29] was used
to create the phylogenetic tree based on Neighbor-Joining
method [30]. 1000 bootstrap re-samplings were performed
to estimate the consensus tree.
Pan- and Core genome estimation
Pan-genome represents the entire gene repertoire and
encompasses core genome and dispensable genome.
Core genome comprised of genes that are present in all
genomes of a given species, and are essential for
bacterial growth, while dispensable sequences do not
necessarily present in all genomes, and may be respon-
sible for strain specific functions like pathogenicity,
stress, resistance etc. [31] A. baumannii conserved core
genome was estimated based on BLAST similarities be-
tween the genomes following previously established 50/
50 rule [32–34]. Blast hit was considered significant
when 50 % of alignment (amino acid) was identical
where the length of alignment was 50 % of the longest
gene in the comparison. According to this criterion,
genes were clustered together in gene families if their
amino acid sequences were at least 50 % identical. Mul-
tiple genes may also make a single gene family if they
follow the same 50/50 rule. Similarly, all genes were
grouped into gene families. The genes that did not fall
in any gene family were assigned to their own unique
gene family. Gene families having at least one gene in
common among them were gathered into the core gen-
ome. Rest of the genes that did not fit into criteria may
go to the species pan-genome [35–37].
Intra- and inter-proteome comparisons
All of the selected genomes were translated into their
proteomes to explore proteomic conservation among
the strains. Pair-wise comparison of proteins was per-
formed and visualized in the form of a matrix [38].
BLASTp comparison was carried out for all the proteins
in one strain to all the proteins in other strains included
in the dataset; and the association was estimated based
on 50/50 rule as previously employed [32, 33]. Each cor-
responding box in the matrix represents the number of
shared proteins and percent homology. For the compari-
son of any two genomes, protein families were built
through single linkage clustering, so that each shared
connection must be between sequences from different
genomes (dark green color represents more homology
between proteomes as shown in Fig. 4). In the matrix,
an internal hit significantly similar to query protein was
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Table 1 Genome statistics of completely sequenced A. baumannii strains
Pan- and Comparative Genomics of Acinetobacter baumannii














1 A. baumannii BJAB07104 NC_021726.1/p1BJAB07104:NC_021727.1;p2BJAB07104:NC_021728.1 4. 0 38.95 3878/3754 3822 3822 3597 3597 3597
2 A. baumannii MDR-TJ NC_017847.1/pABTJ1:NC_017848.1;pABTJ2:NC_020524.1 4.153 39.07 4014/3890 3956 286 268 3862 3454
3 A. baumannii MDR-ZJ06 NC_017171.1/pMDR-ZJ06:NC_017172.1 4.011 39.04 3847/3711 3799 129 123 3984 3272
4 A. baumann;ii TYTH-1 NC_018706.1 3.957 39.00 3754/3628 3697 76 76 4057 3176
5 A. baumannii AC30 CP007577.1/pAC30a:CP007578.1;pAC30b:CP007579.1;
pAC30c:CP007580.1
3.922 38.82 3729/3660 3733 155 147 4203 3145
6 A. baumannii BJAB0715 NC_021733.1/pBJAB0715:NC_021734.1 4.053 38.91 3897/3756 3845 377 359 4560 2940
7 A. baumannii BJAB0868 NC_021729.1/p1BJAB0868:NC_021730.1;
p2BJAB0868:NC_021731.1;p3BJAB0868:NC_021732.1
4.005 38.93 3820/3689 3762 55 55 4610 2899
8 A. baumannii ZW85-1 NC_023028.1/ZW85p2:NC_023031.1;pAbNDM-1:NC_019985.2 3.925 39.20 3684/3553 3625 237 234 4836 2847
9 A. baumannii AC29 NZ_CP007535.2 3.851 39.00 3659/3581 3613 11 10 4842 2834
10 A. baumannii AB031 NZ_CP009256.1 3.803 39.20 3595/3472 3521 241 224 5060 2754
11 A. baumannii AB030 NZ_CP009257.1 4.335 39.00 4336/4155 4285 549 334 5387 2715
12 A. baumannii Abh12
OA2
NZ_CP009534.1 3.875 39.10 3674/3563 3609 74 73 5454 2700
13 A. baumannii LAC-4 NZ_CP007712.1/pABLAC1:NZ_CP007713.1;pABLAC2:NZ_CP007714.1 3.968 38.98 3821/3683 3768 194 194 5640 2645
14 A. baumannii 6411 NZ_CP010368.1/p6411-66.409 kb:NZ_CP010903.1;p6411-
89.111 kb:NZ_CP010369.1;p6411-9.012 kb:NZ_CP010370.2
4.061 38.75 3840/3686 3780 408 403 6038 2580
15 A. baumannii 6200 NZ_CP010397.1/p6200-114.848 kb:NZ_CP010398.1;
p6200-47.274 kb:NZ_CP010399.1; p6200-9.327 kb:NZ_CP010400.1
4.073 39.18 3876/3762 3823 193 193 6230 2541
16 A. baumannii NCGM 237 NZ_AP013357.1 4.021 39.10 3894/3783 3838 93 93 6319 2527
17 A. baumannii IOMTU433 NZ_AP014649.1/pIOMTU433:NZ_AP014650.1 4.190 39.11 3999/3894 3926 242 237 6553 2527
18 A. baumannii A1 NZ_CP010781.1/pA1-1:NZ_CP010782.1 3.917 39.28 3735/3634 3650 140 134 6684 2513




4.066 39.04 3929/3827 3867 89 70 6751 2511
20 A. baumannii XH386 NZ_CP010779.1/pAB386:NZ_CP010780.1 4.199 39.16 4062/3961 3991 27 27 6778 2511
21 A. baumannii Ab04- MFF NZ_CP012006.1/pAB04-1:NZ_CP012007.1/pAB04-2:NZ_CP012008.1 4.192 38.91 4067/3944 4009 84 82 6856 2505
22 A. baumannii ACICU NC_010611.1/pACICU1:NC_010605.1;pACICU2:NC_010606.1 3.996 38.90 3802/3613 3782 80 80 6927 2496
23 A. baumannii AtCC MFF NZ_CP012004.1/pAB3:NZ_CP012005.1 4.006 38.94 3797/3688 3729 145 143 7066 2485
24 A. baumannii AB307-
0294
NC_011595.1 3.760 39.00 3511/3363 3467 67 67 7127 2482
25 A.baumannii AB0057 NC_011586.1/pAB0057:NC_011585.1 4.059 39.18 3890/3669 3879 104 101 7218 2473
26 A. baumannii AYE NC_010410.1/p1ABAYE:NC_010401.1; p2ABAYE:NC_010402.1;
p3ABAYE:NC_010404.1; p4ABAYE:NC_010403.1














Table 1 Genome statistics of completely sequenced A. baumannii strains (Continued)
27 A. baumannii D1279779 NC_020547.2/pD1279779:NC_020525.1 3.711 38.98 3523/3381 3473 88 87 7341 2459
28 A. baumannii 1656-2 NC_017162.1/ABKp1:NC_017163.1;ABKp2:NC_017164.1 4.023 39.08 3882/3733 3837 51 48 7385 2459
29 A. baumannii TCDC-
AB0715
CP002522.2/p1ABTCDC0715;p2ABTCDC0715 4.218 38.89 4010/3956 4054 37 32 7408 2458
30 A.baumannii ATCC 17978 NC_009085.1/pAB1:NC_009083.1; pAB2:NC_009084.1 4.001 38.88 3469/3367 3951 212 210 7606 2445
NCBI database was accessed to retrieve the chromosomal and plasmid sequences of the included strains. Genome size, GC content, number of genes and proteins contained in an isolate were estimated. Genes/
proteins in all the included strains were predicted by using Prodigal. Comparative genomics approaches were employed to estimate the pan- and core genome, new genes and gene families among the strains. The














grouped into the same gene family. The bottom row in
the matrix depicts the number of proteins that have
homologous hits within the proteome itself (internal
paralogs, shaded in red color, from 2.9 % least to 7.0 %
highest illustrated in Fig. 4). Different levels of homology
between the sequences were represented by different
color intensities in the matrix (Fig. 4). Pan-core tree was
generated based upon shared gene families between the
strains. The relative Manhattan distance showed the
evolutionary distance between the strains.
Functional categorization of the core proteome
To prioritize potential core vaccine candidates, the core
genome of all A. baumannii (30 genomes) strains was ex-
plored for the presence of essential genes using Database
for Essential genes (DEG) [39]. Parameters set for BLAST
against DEG were: E-value cut off 1e-10 and minimum bit
score 100. Essential genes of bacteria are an effective thera-
peutic target, especially when bacteria confer multidrug re-
sistance [40]. The core proteome was aligned with human
proteome to pool out the human homologs, so as to elim-
inate the chances of autoimmunity [41]. Proteins having
percentage identity <35 % and E-value <0.005 were consid-
ered as non-host bacterial proteins. Subsequently, virulent
proteins were also estimated within core proteome by using
Virulence factor database (VfDB) [22] and microbial viru-
lence database (MvirDB). Blastp search was carried out
against all the virulence associated protein by employing
the following parameters: Bit Score > 100, E-Value < 1.0 e-5
and percentage Identity > 35 %. The database VFDB con-
tains substantial information of virulence factors from 30
important bacterial pathogens (including Acinetobacter spe-
cies), virulence associated genes, pathogenecity islands, pro-
tein structure and function characteristics. MvirDB is
another comprehensive database for the identification of
virulence factors, antibiotic resistance genes and protein
toxins. It retrieves data from eight public access sequence
databases and facilitates in rapid characterization of se-
quences related to virulence and pathogenesis [25]. PsortB
was used to analyze the sub-cellular localization of proteins
[42]. PsortB helps in sorting out the bacterial proteins as
cytoplasmic, extracellular, periplasmic, outer and inner
membrane. Proteins located in extracellular, periplasmic
and outer membranes were preferred as effective vaccine
candidates [43]. Topology Data Bank of Transmembrane
Proteins, RRID:SCR_007964 (HMMTOP) was used to
predict the localization of helical trans-membrane segments
and topology of transmembrane proteins [44]. Proteins
with ≤1 trans-membrane helices were selected as
appropriate vaccine target as it is easy to purify, clone and
express them [45]. Eventually, those proteins which were
essential, virulent, non-host homologs, exposed or secreted
with ≤1 trans-membrane helices prioritized as vaccine
candidates. The molecular weight of the prioritized
proteins was estimated by employing Expasy PI/MW
tool (RRID:SCR_012880) [46]. Those proteins having
molecular weight of <110KDa were finally designated as
potential vaccine candidates as they can be easily purified
and can be effectively used for vaccine development [47].
Epitope mapping of the targeted proteins
The concept of peptide vaccines is based on identification
and synthesis of B and T-cell epitopes which are immune-
dominant and can generate significant specific immune
responses [48]. Immuno-informatics involves various
combinatorial computational approaches to predict B and
T-cell epitopes [49]. The prioritized proteins obtained by
following the above mentioned strategy were subjected to
sequential epitope mapping steps. Selection of candidate
immunogenic MHC class I and II restricted peptides from
characterized proteins is the key to successful vaccine de-
velopment [50]. ABCpred was employed (threshold value
>0.6) to retrieve the B-cell epitopes from the prioritized
proteins. ABCpred predicted the B-cell epitopes based on
artificial neural networks [51]. The 20-merB-cell epitopes
were subsequently analyzed for T-cell epitopes for binding
with MHC I and MHC II class molecules by using
Proped1 and Proped servers, respectively [52]. The cap-
ability of an antigen to generate immune response de-
pends upon its recognition and binding with MHC alleles
from both classes I and II [53]. Surface exposure of T-cell
epitopes was estimated by using NetSurfP [54]. Vaxijen
v2.0 was used to check the antigenicity of the epitopes
(threshold value >0.4) [14]. The epitopes having values
more than 0.4 were considered potentially antigenic.
MHCpred was used to calculate the half maximal inhib-
ition concentration (IC50) score for DRB1*0101 (a com-
mon and prevalent allele in worldwide population) [55,
56]. Various in silico reverse vaccinology studies targeting
bacterial infections, including A. baumannii, preferred the
epitopes which bind with DRB1*0101 allele, as this will
lead to strong antigen recognition and immune response
[41, 57, 58]. IC50 values are binding affinity measures cal-
culated from a competitive binding assay [59]. Prediction
of MHC binding is a prerequisite to the prediction of T-
cell epitopes. Estimation of binding peptides is simplified
by following a classification scheme, dividing the peptides
into non-binders, low affinity binders (>500nM), medium
affinity binders (50–500nM) and high affinity binders
(<50nM) [48]. Virulence of the candidate epitopes was es-
timated by using VirulentPred [60].
Epitope conservation analysis
A conservation analysis is performed to estimate the
level of sequence conservation in the epitopic regions
across the included strains of A. baumannii (prioritized
proteins). The conservation analysis of these epitopes
was performed by using CLC main workbench [61]. This
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user-friendly, graphically based software performs the
multiple sequence alignment, and consensus sequence
was derived for the epitopes. The overall conservation of
the sequences was predicted and displayed with the
alignment (Fig. 7). The degree of similarity or variability
of a specific protein or epitopic region may provide sig-
nificant information regarding structural, functional,
evolutionary and immunological correlates.
Protein structure and comparative modeling
Visualization of 3D structure of proteins facilitate in
understanding the sequence patterns, functional sites,
binding sites and interactions of candidate proteins
with other targets [62]. Protein Databank (PDB,
RRID:SCR_012820) and Swiss model (SWISS-MODEL
Repository, RRID:SCR_013032) were employed to ex-
plore 3D structures of the query proteins by compara-
tive modeling [63, 64]. Comparative modeling method
make use of experimental protein structures (tem-
plates) to build models for target proteins [63, 65].
Swiss model was employed for each of the query pro-
tein and among the number of templates generated by
the server (BLAST), one with highest sequence iden-
tity/similarity was selected. For example, the query se-
quence adeK exhibited 45.85 % sequence similarity with
outer membrane protein OprM (PDB id-3d5k.1.A)
which was further assessed for epitope visualization by
pepitope. Similarly, for query proteins P pilus assembly
protein, pili assembly chaperone, PonA, general secretion
pathway protein D (HMPREF0010_02518), FhuE receptor,
Type VI secretion system OmpA/MotB, Ton B dependent
siderophore receptor, general secretion pathway protein D
(HMPREF0010_01958), outer membrane protein, peptido-
glycan associated lipoprotein and peptidyl-prolyl cis-trans
isomerase, PDB structures with highest sequence similarity
were selected, i.e., PDB ID: 3rfz.1.B, 1ze3.1.A, 3udi.1.B,4a-
v2.1.A,2w77.1.A, 2n48.1.A, 1fep.1.A, 4e9j.1.A, 3d5k.1.A,
4g4v.1.A and 1q6u.1.A, respectively. Surface exposure of
candidate epitopes on the proteins facilitates in generation
of strong immunogenic response [66]. Pepitope was
employed to reveal the topology of epitopes within the pro-
tein structures [67]. It is essential to ensure the arrange-
ment of the epitopes so that the immunogenic part does
not get folded within the globular protein [41].
Functional annotation of the predicted proteins
Functional analysis assists in studying the biological, mo-
lecular and biochemical behavior of the proteins. Here
the Blast2GO (RRID:SCR_005828) was employed for
functional annotation of the prioritized proteins [68].
Cluster of orthologous groups (COG) and biological/
molecular pathways were explored for the prioritized
proteins as reported in Kyoto encyclopedia of genes
and genomes (KEGG) database (http://weizhongli-
lab.org/metagenomic-analysis/server) [69].
Targeted protein-protein interaction (PPI) analysis
Interaction analysis of prioritized proteins was executed
by using Search tool for the retrieval of interacting genes
(STRING, RRID:SCR_005223) [70]. The association of
query proteins with the predicted functional partners is
represented by thick blue lines. Colored nodes represent
that the interacting partners directly link to the targeted
proteins with optimal score of 0.9. Interactions among
the proteins constitute backbone of cellular function and
the study of such interactions helps in understanding
molecular mechanism and biological processes, elucidat-
ing molecular basis of diseases and identifying potential
therapeutic targets [71].
Validation of pipeline through positive control
To test the functionalities of the pipeline and validation
of the predictions, additional potential vaccine candi-
dates are predicted against another Gram negative bac-
terium as a positive control such as Helicobacter pylori.
The same methodology and pipeline is employed to
analyze the genome of H. pylori strain reference strain
26695 to find the vaccine targets against this important
organism, so as to limit its incidence and eventually the
associated gastric cancer.
Results
Genome organization and statistics
The drug resistant A. baumannii has increasingly become a
cause for serious concern with regard to both nosocomial
and community acquired infections [4]. Due to next gener-
ation sequencing technology, there is wide-ranging avail-
ability of genome data on international databases. To date,
30 complete genome sequences of A. baumannii are avail-
able on GenBank/NCBI, which were all analyzed for poten-
tial vaccine candidates in our study (Table 1). The total
number of proteins in all of the available complete genomes
(30 A. baumannii genomes) was calculated as 114,872 and
an average A. baumannii genome/proteome contain 3,829
proteins. An average GC content is observed around
39.03 %. The average gene count was found out to be 3829
genes (3702 proteins), with lowest number of genes re-
ported in a 50-year old isolate A. baumannii ATCC 17978
(3,469) and highest number of genes were reported in a
newly sequenced extremely drug resistant A. baumannii
AB030 (4,336). As a consequence of strong antibiotic se-
lective pressure, the bacteria have acquired significant anti-
biotic resistance and virulence genes for their survival over
the period of time [72]. To get a consistency in the genomic
and proteomic data all the sequences were assessed by a
single gene prediction program Prodigal which predicted
more number of genes in analyzed genome sequences
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when compared with that of NCBI (Table 1). However, the
overall numbers are comparable, this increase in prediction
by the Prodigal may be due to its improved translation initi-
ation site recognition [15].
Virulence potential of A. baumannii
Relative to other gram negative pathogens, very little is
known in relation to the pathogenic potential and virulence
repertoire of A. baumannii [73]. To get insight into the
virulence potential of A. baumannii, virulent genes present
in core conserved genome were explored. Interestingly, the
bacteria harbor a significant number of virulent genes (295)
as part of its core genome which facilitates the organism in
pathogenesis and probably survival in adverse conditions
(Additional file 1). In the conserved virulome of A. bau-
mannii genus, the major virulence factors and associated
mechanisms are identified which include OmpA, pili as-
sembly proteins, superoxide dismutase, phospholipases, sid-
erophore dependent iron acquisition proteins, multidrug
efflux proteins, and penicillin binding proteins. Among
them, the significant protein OmpA is involved in the
process of epithelial invasion and apoptosis [74]. Similarly,
pili assembly proteins play vital role in bacterial adherence
and biofilm formation; thus imperative for pathogenesis of
A. baumannii [75]. Another important factor, superoxide
dismutase found to be present in the core genome assist
bacteria by detoxifying reactive oxygen species released in
the course of host defense reactions [76]. Like OmpA, the
phospholipase C are responsible for survival in human
serum and epithelial cell invasion [75]. Upregulated iron
acquisition systems and antibiotic efflux pumps further en-
hance the virulence potential of A. baumannii [77].
For a pathogen the virulence mechanism is necessary
to overcome the host defense systems and to survive in
the competitive and demanding environments (new
niches) [78]. Clonal distribution of virulence factors re-
vealed that many of the significant virulent factors are
restricted to specific clonal lineages (I and II). For in-
stance, isolates belonging to international clone I (A.
baumannii AYE, A. baumannii A1, A. baumannii 0057)
exhibits common virulence factors such as Tn21 inte-
grase, streptomycin adenyltransferase, chloramphenicol
acetyltransferase, TnmP and transposase. The role of
transposon Tn21 in global dissemination of virulence
and antibiotic resistant genes have already been explored
in Gram negative facultative bacteria [79]. The presence
of these virulence determinants in specific clone sug-
gests these are crucial for the success of these widespread
common clones. Likewise, in IC II strains, certain viru-
lence factors prevail including phosphomannumatose,
type4 pilus assembly protein, heat shock protein 60, tet
repressor and tetracycline resistance proteins (Table 2).
Presence of important virulence factors in core con-
served proteome shows that bacteria has strongly
evolved as super bug, and horizontal gene transfer could
be answer to this significant phenomenon [80].
Phylogenetic analysis of A. baumannii strains
Phylogenetic analysis was performed for all the included
A. baumannii strains to understand the pattern of
Table 2 Significant virulence factors in A. baumannii strains
Virulence
factors
International Clone I International Clone II Function
A. baumannii A. baumannii
AYE A1 AB0057 AB307-0294 ACICU MDRTJ MDR-ZJ06 TCDC-AB0715 1656 BJAB0868
Intl1 + + + - + + + + + - Tn21 integrase
aadA1 + + + - - + + + Streptomycin adenyltransferase
Cat + + + - - + - - Chloramphenicol acetyltransferase
tnpM + + + - + + + + - - TnmP
tnpA + + + - - - - - - - Transposase
tnpH + + + - - - - - - Hypothetical protein
htpB - - - + + - + + + + Heat shock protein60
manB - - - + + - + + + + Phosphomannumutase
pilF - - - - + + - - + + Type4 pilus assembly protein
tetR - - - - - + + + - + Tet repressor
tetAB - - - - - + + + - + Tetracycline resistance protein
The signs + and – in the table denote presence or absence of genes, respectively. BLASTp search on Virulence factor database (VFdb) revealed sharing of common
virulence factors in A. baumannii strains belonging to the international clone I and II. Virulence factors like Tn21 integrase and streptomycin adenyltransferase are
frequently shared by strains of both international clone I and II. Transposases (tnpA, tnpH) and chloramphenicol acetyltransferases are mostly expressed in strains
A.baumannii AYE, A.baumannii A1 and A.baumannii 0057 of IC I. Occurrence of specific virulence factors in IC I and IC II illustrates the evolution of the bacteria as
the super bug in certain geographical locations and its survival in localized environments
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evolution. The 16SrRNA distance tree illustrates the gen-
etic distances between the closely related sequences. The
phylogenetic tree resulted in two main clusters corre-
sponding to IC I (A. baumannii AB307-0294, A. bauman-
nii AB0057, A. baumannii AYE, A. baumannii A1) and
IC II (A. baumannii BJAB07104, A. baumannii MDRTJ,
A. baumannii MDRZJ06, A. baumannii TYTH1, A. bau-
mannii AC30, A. baumannii BJAB0715, A. baumanni
TCDC, A. baumannii AB031, A. baumannii ZW85, A.
baumannii BJAB0868, A. baumannii AC29, A. baumannii
ACICU, A. baumannii 1656-2). Selective environmental
pressures have led to evolution of strains in specific geo-
graphical and ecological niches [81]. A. baumannii
D1279779 expressed as a separate branch of the tree, val-
idating the unique properties of this strain in between IC I
and IC II (Fig. 2) as reported by Ferrugia et al. [82]. The
recently isolated bloodstream related A. baumannii
AB031 exhibited over expression of AdeABC efflux pump,
resulting in tigecycline resistance, emerged as a separate
branch in the tree [83]. A. baumannii IOMTU433 (carry-
ing multiple antibiotic resistance genes notably blaNDM-
1, blaOXA-23, blaOXA-104, blaPER-7, armA) [84] and A.
Fig. 2 Evolutionary relationships of the A. baumannii strains based on 16SrRNA sequences. The evolutionary history was inferred using the
Neighbor joining method. 1000 bootstrap re-samplings were done to estimate the consensus tree. The optimal tree with a sum of branch length =
0.5833 is shown. The tree is drawn to scale with branch lengths in same units as those of evolutionary distances used to infer the phylogenetic tree.
The evolutionary distances were computed using the maximum composite likelihood method and are in the units of the number of base substitutions
per site. a Illustrates the complete phylogenetic tree of all the included strains and b shows the enhanced view of the selected clads. The strains like A.
baumannii AYE, A. baumannii A1, A. baumannii 307-0294 all belonging to IC I fall in the same clade, indicating phylogenetically closeness to their clonal
strains. A. baumannii D1279779 expressed as a separate branch of the tree, validating the unique properties of this strain in between IC I and IC II.
Similarly strains belonging to IC II appeared in single clad, showing their close phylogenetic relationships
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baumannii Ab04-mff make separate clad indicating they
are phylogeneticaly distant from their clonal strains.
Evolution of genome composition and pangenome
Comprehensive pan-genome analysis studies can help to
understand the functional adaptation of a bacterial spe-
cies. In the present study, analysis of A. baumannii pan-
genome revealed 7,606 coding sequences, of which 2,445
represent core and the remaining 5,161 constitute the
dispensable genome. The dispensable genome makes the
pan-genome relatively large because of the presence of
expansive pool of dispensable genes from various strains.
It is observed in the pan-core plot (Fig. 3), that there is a
subsequent increase in pan-genome with the addition of
new genome, and the core genome decreases with the
addition of second genome and so on. We have observed
the stability in the core genome while adding third, forth
and so on, and finally a conserved set of 2,445 genes was
obtained representing the core gene repertoire (Fig. 3) of
the selected A. baumannii genomes. This core genome
is about 64 % of the average genome, which is indicative
of the highly conserved genomic features (Additional file
2). Under the selective environmental and antibiotic
pressures bacteria acquire genes via horizontal gene
transfer, supporting their survival in a specific conditions
[85]. The enormous exposure of broad spectrum antibi-
otics over the years has led this bacterium to acquire
foreign genes and up regulate its innate resistance mech-
anisms [86]. We observed from our analysis that accu-
mulation of an average of 258 new gene families arises
in strains, with the highest number of strain specific
(unique) new gene families observed were 359, 234, 334,
403 in A. baumannii BJAB0715, A. baumannii ZW85-1,
A. baumannii AB030 and A. baumannii 6411, respect-
ively (Table 1). Pan-core tree is also generated (Fig. 4)
based upon shared gene families between the strains
which is a representative tree for the distribution of ge-
nomes. The distribution of genomes is found compar-
able with that of the phylogenetic tree based on
16SrRNA. The findings (pattern of distribution into dif-
ferent clads) are also comparable to whole proteome/
blast matrix results. For example, the strain A. bauman-
nii TCDC, A. baumannii MDR-Z, A. baumannii
BJAB07104, A. baumannii BJAB0868 and A. baumannii
TYTH-1 are closely related to each other on phylogen-
etic analysis and also on matrix (Fig. 4) exhibiting more
than 80 % similarity in their protein content, with each
other.
Proteome comparison analysis (Intra- and Inter proteome
conservation)
The proteome of all the A. baumannii strains was com-
pared to estimate the amount of proteins they share.










Genes Pan genome Core genome
Fig. 3 Pan- and core genome plot of A. baumannii strains. The X-axis in the graphs denotes all the A. baumannii strains included in our study
and Y-axis indicates the number of genes expressed in each strain. The green line in the chart indicates the gradual pan-genome expansion and
the red line shows the core genome development/conservation with addition of each genome. The blue bars represent the number of genes
present in each of the strains. Comparative genomics analysis of all the included strains led us to pan-genome estimation, comprising of 7606
coding sequences, of which 2445 represented core genome. In the pan-core plot, there is a subsequent increase in pan-genome with the
addition of next genome, and the core genome decreases with the addition of second genome and so on, till a conserved set of 2445 genes
attained representing the core gene repertoire. The stable core genome suggests that it can be explored for identification of conserved vaccine
candidates. The gradual extension of the pan-genome with addition of new genome suggests an open pan-genome of A. baumannii. The
number of genes that each strain contains can be documented from comprehensive statistical analysis given earlier in Table 1
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the pair-wise comparison of proteomes (Fig. 4). The
number and percentage of shared proteome was shown
in corresponding box of the matrix (Fig. 4). The max-
imum protein conservation i.e., 95.8 %, was found
among two carbapenem resistant strains, A. baumannii
AC29 and A. baumannii AC30 strains, both isolated
from tertiary care hospital in Malaysia. These two strains
belonged to international clone II and had identical Apa
I pulsotype [87]. Minimum protein conservation was
60.8 % between A. baumannii 6411 and A. baumannii
AB030 strains, both exhibiting diverse antibiotic resist-
ance genes. A. baumannii 6411 possessed blaNDM-1
gene which conferred resistance to carbapenems and
cephalosporin, and A. baumannii AB030 categorized as
extremely drug resistant pathogen (showing resistant to
all groups of antibiotics except colistin) [88]. There are
certain homology blocks in figure shaded dark green
suggest more homology. Block1 (marked in the Fig. 4 as
blue colored box) showed homology of more than 80 %
between strains A. baumannii TCDC and A. baumannii
1656-2 with A. baumannii BJAB7104, MDR-TJ, MDR-Z,
TYTH-1 and AC30, all belonging to IC II. Similarly, in
block 2, three strains of IC I (A. baumannii AYE,
AB0057, AB307-0294) showed more than 83 % hom-
ology with other IC I strains, A. baumannii A1 and A.
baumannii AB5075 (marked in the Fig. 4 as a red col-
ored box). The results of the BLAST matrix were found
interesting as it can be compared to phylogenetic tree.
For example, it can be seen that A. baumannii strain
TYTH-1 exhibits more than 70 % homology with rest of
A. baumannii strains and it is seen from the distance
tree that these strains have evolved from a common an-
cestor and share common proteomes. Highest internal
homology within proteome was seen in A. baumannii
strain TCDC and A. baumannii AB030 i.e., 7 and 6.7 %
respectively (Fig. 4). The relatively high proteome con-
servation in A. baumannii strains, for example 95.8 %
homology in two carbapenem resistant strains clinical
isolates, make these organism suitable to be targeted for
broad spectrum therapeutics and there is a need to esti-
mate the size of the pan-genome of the genus (closely
related species).
Core proteome estimation for essentiality and non-host
homologs
The identification of essential genes is a crucial step in de-
signing therapeutic targets against bacterial infections be-
cause of the fact that most of the antibiotics and vaccines
target essential cellular processes [27]. Among the 2445
core proteins, 956 (39 % of core proteome) were predicted
as essential genes (blue bar in Fig. 5) (Additional file 3)
[89]. Essential genes, comprised of minimal gene set re-
quired to support cellular life, have much wider therapeutic
potential being antibacterial drug targets and vaccine
386
Fig. 4 Whole proteome pair-wise comparisons of A. baumannii strains. The names of strains along with the number of proteins and protein families
are mentioned along each side of the matrix. Each box in the matrix depicts the fractions of shared proteins between the two corresponding strains.
The homology between the proteomes is depicted in green color (dark green color represents more homology between proteomes). The number
and percentage of shared proteome is also shown in the corresponding box of the matrix. The last row in the matrix depicts the homology
within the proteomes and indicated as internal homologies in individual strain (genome/proteome) and are shaded in red color, the scale given
showed 2.9 % least to 7.0 % the highest). Two homology blocks (marked in figure as red and blue color) shaded dark green suggest strong
homology among the strains. Strains in red and blue block belong to international clone I and II, respectively. The blue block showed homology
of more than 80 % between strains A. baumannii TCDC and A. baumannii 1656-2 with A. baumannii BJAB7104, MDR-TJ, MDR-Z, TYTH and AC30.
Similarly, in red block three strains (A. baumannii AYE, AB0057, AB307-0294) showed more than 83 % homology with A. baumannii A1 and A.
baumannii AB5075. Highest internal homology within proteome was seen in A. baumannii strain TCDC and A. baumannii AB030 i.e., 7 % and
6.7 % respectively. The matrix results are comparable to pan-core dendogram. Pancore dendrogram is based upon the shared gene families
among the strains. IC I and II strains in the red and blue blocks in the matrix, respectively, make separate clads in the tree, indicating the
phylogenetic correlation of the strains
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targets [90]. The essential genes in A. baumannii are in-
volved in major biological processes like survival in extreme
conditions/stress, infection and persistence in host, nucleic
acid binding, ATP and GTP binding, ligase, transferase and
phosphatase activity. The core sequences were aligned with
human proteome to confirm if there is any similarity be-
tween them. Among 2445 core proteins, 2131 proteins
(green bar in Fig. 5) showed hits below the threshold value
and were considered as non-host bacterial proteins. These
non-host proteins/genes are preferred for vaccine develop-
ment to avoid the generation of autoimmune response or
recombination and integration events in the host genome
[91]. The details of core proteins, essential, virulent, non-
host homologs proteins are provided in Additional file 4.
Vaccine candidates identification
The presence of core genes in the bacterial genomes is an



























































Total number of Proteins
Fig. 5 Categorization of core proteome of A. baumannii. Illustration of possible correlations between different parameters for the
prioritization of core proteome of A. baumannii strains. a Depicts the generation of the prioritized proteins among the core proteins,
selected on the basis of sub-cellular localization, virulence, essentiality and non-host homologs. Core proteins are represented in green
circle of the Venn diagram, non-host homologs proteins in blue, essential proteins in purple, virulent proteins in light blue and secreted
proteins in red color. The numbers presented in the overlapping regions of the circles show the number of strains exhibiting a particular
set of category. 13 proteins among the core proteins have been prioritized, as they simultaneously share all four properties (secreted,
essential, virulent, non-host homologs). The proteins satisfying all these criteria were taken into consideration for further epitope mapping
approaches. b Demonstrates the individual categories i.e., core proteins (green bar, 2,445 proteins), non-host homologs proteins (blue bar,
2,131), essential proteins (purple bar, 956), virulent proteins (light blue bar, 295), and secreted proteins (red bar, 19). c Depicts the number
of proteins sharing the specific number of attributes (essentiality, virulent, sub-cellular localization, non-host homologs). The scale shifts
from dark purple color (1 list) to light color (2, 3, 4 lists)
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represents an ideal dataset for the exploration of suitable
vaccine candidates against A. baumannii. It was subjected
to sequential steps in order to find proteins which are at
surface or secreted, and at the same time essential, viru-
lent and non host homologs. Proteins prioritized after
passing through these criteria were taken as suitable vac-
cine candidates and were further explored for their epi-
topes, protein-protein interactions, surface topology,
comparative homology modeling and comprehensive
functional analysis. The detailed methodology is described
in the subsequent sections.
Sub-cellular localization
Core proteins estimation for sub-cellular localization re-
vealed that 1289 proteins were cytoplasmic, 552 located on
cytoplasmic membrane, 65 outer membrane, 45 periplas-
mic, 19 extracellular (Additional file 5) [42]. Knowledge of
the sub-cellular localization of a protein can significantly
improve therapeutic target identification [93]. For example,
plasma membrane and secreted proteins are easily access-
ible by drug molecules due to their localization in the extra-
cellular space or on the cell surface. Bacterial cell surface
and secreted proteins are of interest for their potential as
vaccine candidates or as diagnostic targets [94] (Fig. 6).
Epitope mapping of prioritized proteins
Prioritization and filtration of the identified proteins
could help to minimize the time, labor and resources
for developing vaccine candidates and optimize the
success of getting the best drug or vaccine against the
pathogen. Parameters of essentiality, virulent, non
host homologs and sub-cellular localization were
summed up and 13 core proteins have been observed
as potential vaccine targets including P pilus assembly
protein, pili assembly chaperone, AdeK, PonA, OmpA,
general secretion pathway protein D, FhuE receptor,
Type VI secretion system OmpA/MotB, Ton B
dependent siderophore receptor, general secretion
pathway protein D (HMPREF0010_01958), outer
membrane protein, peptidoglycan associated lipopro-
tein and peptidyl-prolyl cis-trans isomerase. These
proteins found out to fit in the criteria of trans-
membrane helices (less than 2) and exhibited molecu-
lar weight of <110KDa [46]. Antigenicity analysis by
using Vaxijen v2.0 revealed that the 13 prioritized pro-
teins are potentially antigenic and exhibited score of
more than 0.4 (Table 3). These target proteins were
considered as potential vaccine targets and subjected
to epitope mapping approaches. The 20-mer B-cell
epitopes were predicted for each protein and were
further filtered based upon the common T-cell epi-
topes binding with both MHC I and II molecules
(Proped and Proped1). Subsequently, the T-cell epi-
topes binding to a maximum number of MHC I and II
class molecules, with optimal IC50 values for
DRB1*0101 were selected. In our study, the ten priori-
tized proteins were found out as high affinity binders
with IC50 values less than 50nM i.e., general secretory
protein D (HMPREF0010_01958) (61.94nM), OmpA
(1.99nM) ponA (12.76nM), pili assembly chaperone
(93.3 nM), general secretion pathway protein D
(HMPREF0010_02518) (49.89nM), Ton B dependent
siderophore receptor (3.63nM), outer membrane pro-
tein (57.68nM), peptidoglycan associated lipoprotein
Fig. 6 Sub-cellular localization of core proteome for prioritization of vaccine candidates. Core proteins (2445) were analyzed for their sub-cellular
localization by using PsortB. A large number (53 %) of proteins were found to be cytoplasmic, followed by 22 % in the cytoplasmic membrane.
Proteins situated in outer membrane (3 %), extracellular (1 %) and in periplasmic space (2 %) were preferred to be considered for putative vaccine
candidates, as these can be readily recognized by MHC molecules and generate strong immunogenic response
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(1.24nM), AdeK (12nM), P pilus assembly protein
(11.97nM). Proteins including peptidyl-prolyl cis-trans
isomerase (176nM), FhuE receptor (186.64 nM), Type
VI secretion system OmpA/MotB (55.72nM) and P pi-
lus assembly protein (267nM) fall in the category of
medium affinity binders (Additional file 6).
The 9-mer sequence YQQVPSGGK from general secre-
tion pathway protein D (HMPREF0010_01958) is surface
exposed T-cell eptiope which exhibited antigenicity score
of 0.64. The T-cell sequence YNVDASRLS from outer
membrane protein OmpA can bind with total of 12 MHC
1 and MHC 11 class molecules, and is highly antigenic
(1.61, Vaxijen score) and exhibited the lowest IC50 value
for DRB1*0101 allele (1.99nM).The epitope YSGDSQLNA
from Ton B dependent siderophore receptor fall in the
category of medium affinity binder with seven out of nine
surface exposed epitopes and Vaxigen antigenicity score of
1.42. Penicillin binding protein PonA revealed 9-mer com-
pletely surface exposed epitope FLIIIIILV with highest
anitgenicity score of 2.12 and also bind with maximum
number of MHC I and II [54] class molecules. The 9-mer
sequence YNSASGTSI from outer membrane protein
AdeK can bind with total of 30 MHC class I and II alleles,
and is antigenic (1.93, Vaxijen score) and exhibited the
Table 3 Prioritized core vaccine candidates against Acinetobacter baumannii













P pilus assembly protein
(HMPREF0010-00599)
WGDESNERC 820-829 18 1.85 1.0600 COG3188 P pilus assembly
protein, porin PapC
adeK YNSASGTSI 44-52 30 1.9336 1.0621 COG1538 Multidrug resistance
outer membrane
protein















IQSSGSYEY 221-229 12 1.1190 1.0606 COG4796 Type II secretory
pathway
Type VI secretion system
OmpA/MotB
(HMPREF0010_01378)




























FLIIIIILV 15-23 54 2.1254 1.0606 COG5009 Cell wall/membrane
biogenesis
Thirteen putative proteins including P pilus assembly protein, pili assembly chaperone, adeK, ponA, ompA, general secretion pathway protein D, FhuE receptor,
Type VI secretion system OmpA/MotB, Ton B dependent siderophore receptor, general secretion pathway protein D (HMPREF0010_01958), outer membrane
protein, peptidoglycan associated lipoprotein and peptidyl-prolyl cis-trans isomerase have been identified as core vaccine targets by employing in silico reverse
vaccinology approaches. Antigenic 9-mer T-cell epitopes were identified for each protein by comprehensive epitope mapping strategies. A cluster of orthologous
genes (COG) classification and biological/molecular process KEGG description of the potential proteins was determined. Antigenicity and virulence scores were
predicted for each of the candidate epitope
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lowest IC50 value for DRB1*0101 allele (12nM). Outer
membrane protein P pilus assembly protein revealed an
epitope WGDESNERC which has Vaxigen score of 1.85,
virulence score 1.02, total number of MHC binding alleles
18. Likewise, 9-mer surface exposed T-cell epitopes of pi-
lus assembly chaperone, general secretion pathway protein
D (HMPREF0010_02518), Ton B dependent siderophore
receptor, outer membrane protein, peptidoglycan associ-
ated lipoprotein showed appropriate antigenicity and viru-
lence scores and fulfill all the criteria to be characterized
as immunogenic.
Epitope conservation analysis
Among the thirteen epitopes in the prioritized proteins,
ten epitopes belonging showed 100 % conservation pat-
tern among all of the strains of A. baumannii included
in the study, these proteins include AdeK, PonA, OmpA,
general secretion pathway protein D, Type VI secretion
system OmpA/MotB, TonB dependent siderophore
receptor, general secretion pathway protein D, outer
membrane protein, peptidoglycan associated lipoprotein
and peptidyl-prolyl cis-trans isomerase. The alignments,
consensus sequences and the conservation in selected
epitopes (YNSASGTSI, YSGDSQLNA, IAGNQNLKA,
IKEDANLAA) are represented in Fig. 7. Being con-
served, these epitopes could be considered as potential
core candidates to evoke immune response efficiently
within the host against A. baumannii. Three epitopes
WGDESNERC, IKEDANLAA and IKLYDSNVN have
shown conservation of about 80–90 % and these pro-
teins were found to belong to the P pilus assembly pro-
tein, pilus assembly chaperone and FhuE receptor,
respectively. Hence, the consensus sequence is derived
and re-considered for the conservation analysis of the
selected epitopic regions; it showed conservation in the
same amino acids residues to a great extent. The align-
ment and conservation of the rest of the epitopes are
provided in Additional file 7.
Fig. 7 Epitope conservation analysis. The alignments, consensus sequences and the conservation of the epitopes YSGDSQLNA, IAGNQNLKA,
IKEDANLAA and YNSASGTSI belonging to proteins TonB dependent siderophore receptor, outer membrane protein, pilus assembly chaperone
and adeK, respectively, are highlighted in the Figure
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Prioritized proteins structure analysis
The availability of 3D structures of candidate proteins was
checked by using protein databank(PDB) [64] and for non-
characterized proteins, comparative homology modeling
was executed using Swiss-Model [63]. OmpA protein has
an experimentally validated 3D structure available on PDB
(ID: 4g4y). 9-mer T-cell epitope YNVDASRLS expressed
on the surface of OmpA protein (Fig. 7, shown as red
spheres on gray colored protein structure), suggesting sur-
face exposure and recognition of the epitope by MHC mol-
ecules, resulting in generation of strong immunogenic
response. HMMTOP revealed that all the candidate pro-
teins have trans-membrane helices less than 2 and this
topological arrangement convincingly support the effective
vaccine development [44]. Expression of candidate epitopes
on surface of the proteins is imperative, as it would assist in
the generation of strong immunogenic response [95]. The
selected thirteen epitopes from relevant proteins satisfactor-
ily displayed surface exposure and can be exploited as vac-
cine targets against A. baumannii (Fig. 8) [67].
Functional annotation of predicted proteins
Functional analysis of proteins is imperative as it assists in
understanding their physiological behavior, biochemical
activities and biological processes [96]. The selected pro-
teins were found to be involved in significant biological
process including pilus and cell wall organization,
chaperone mediated protein folding and transport across
membrane. Among them, AdeK is an outer membrane ef-
flux protein, encoded by gene oprM, involves in selectively
and non-covalently binding with lipids. It enables the di-
rected movement of macromolecules into, out of, within a
cell or between cells [77]. Another important factor,
OmpA induces apoptosis in laryngeal epithelial cells
through capsases dependent and AIF-dependent pathways
[97]. It enters the cell and localizes to the mitochondria,
and leads to release of pro-apoptotic molecules such as
cytochrome C and apotosis inducing factor [98]. Another
factor, pili assembly chaperone is engaged in crucial steps
of cell wall organization, chaperone mediated protein fold-
ing and pilus organization [99]. Similarly, P pilus assembly
Fig. 8 Pepitope depicted surface topology of predicted potential antigenic epitopes. Gray secondary structure of proteins were predicted by
using Swiss model and red highlighted structures illustrate the surface topology of 9-mer T-cell epitopes on respective proteins. Surface exposure
of epitopes is a requisite for a candidate to be recognized by MHC molecules and be strongly immunogenic. All the predicted vaccine targets
fulfill the antigenicity, transmembrane helices and topology criteria and can be exploited further for in vivo testing
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protein is a fimbrial usher protein and involves in trans-
porter activity [100]. The molecular function of one of the
important core vaccine candidate, PonA involves selective
and non-covalent binding of any antibacterial drug which
contains the condensed beta-lactam thiazolidine ring sys-
tem [101]. The core vaccine candidate, general secretory
pathway protein D is responsible for the secretion of pro-
teins across the outer membrane of bacteria by type II se-
cretion system [102]. At molecular level these protein
were found to be involved in transporter activity, anti-
biotic binding and lipid binding. Another major target,
TonB dependent siderophore receptor is located in cell
outer membrane. It interacts selectively and non-
covalently with iron ions [103]. It is involved in the di-
rected movement of siderophores (low molecular weight
iron chelating substances) into, out of or within a cell, or
between cells by means of a transporter. Similarly, FhuE
receptor is another outer membrane receptor protein re-
quired for the uptake of iron via ferric coprogen and
ferric-rhodotorulic acid [104]. Another core vaccine can-
didate, peptidyl-prolyl isomerases (PPIs) are ubiquitous
proteins and are involved in the cis–trans isomerisation of
peptide bonds N-terminal to proline (Pro) residues within
polypeptide chains. They are significantly engaged in the
folding of newly synthesized proteins and in the function
of the immune system [105]. B2GO facilitate in mapping
and graphical representation of the results (Fig. 9). COG
analysis showed that the candidate seven proteins
belonged to significant groups (Additional file 8) [69]. Pri-
oritized targets were found to be involved in the major
biological and molecular pathways as reported in KEGG
database (Additional file 9) [69, 106]. The filtered proteins,
being essential and virulent, engage in cell wall biogenesis,
secretory system, and assembly of porins, fimbria and re-
ceptors, thus highlighting their importance in cell fitness
and survival.
Protein-protein interactions (PPI) analysis of the
candidate proteins
Proteins in a biological system interact not only with
each other but also with other molecules that mediates
metabolic/signaling pathways and cellular processes
[107]. Predicted thirteen proteins were found to be inter-
related with the important proteins like efflux pump
Fig. 9 Functional annotation of prioritized protein. Protein function prediction and analysis was executed by using BLAST2GO. a Illustrates the
involvement of the proteins in significant molecular functions including trans-membrane transporter activity, receptor activity, drug, lipid, ion,
sulphur compound and amide binding. b Depicts the functional analysis of prioritized proteins based on biological processes. The filtered proteins, being
essential and virulent, engage in cell wall biogenesis, secretory system, and assembly of porins, fimbria and receptors, highlighting their importance in cell
fitness and survival
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proteins, multidrug ABC transporters and multidrug re-
sistant proteins (Fig. 10). Four clusters were established
exhibiting involvement of candidate proteins in signifi-
cant biological processes like transport, cell wall biogen-
esis and binding (Fig. 9). PonA (penicillin binding
protein 1a) and general secretion pathway protein D
(HMPREF0010-02518) interacts with a group of Type IV
pili proteins including Tfp pilus assembly protein PilP,
type IV fimbrial biogenesis protein PilO and type IV pi-
lus assembly protein PilM. These interactions suggest
that the bacteria possess flagellum independent surface
associated motility, and PonA and general secretion
pathway protein D assist the type IV pili multi-proteins
in exhibiting this property in A. baumannii [108]. P pilus
assembly protein and pili assembly chaperone make a
separate cluster and interact with other pili assembly
chaperones and fimbrial proteins. In a separate cluster,
AdeK (outer membrane efflux protein oprM) has close
interactions with large family of AdeI, AdeJ, AdeA and
multidrug ABC transporter [109]. Another of our core
priortized protein FhuE receptor closely interacts with
Ton-B dependent siderophore receptor, indicating the
dual mechanism which facilitates bacteria to survive in
iron-limiting conditions [110]. In another cluster,
OmpA, peptidoglycan associated protein and Type VI
secretion system OmpA/MotB interacts with tolB which
is involved in TonB independent uptake of molecules
[111]. By analyzing the PPI network graphs, genetic/
metabolic correlations and the co-localizations of the
proteins were determined. Protein interaction networks
facilitated in understanding the evolution of individual
proteins and the different systems in which they were in-
volved. These helped to suggest functions for the pro-
teins by revealing their roles in pathways and protein
complexes [112].
Validation of pipeline through positive control
H. pylori genome subjected to the same prediction
process revealed five significant vaccine candidates
which includes vacA, babA, sabA, fecA and omp16. The
pipeline successfully identified already known immuno-
genic targets (vacA) [113] along with novel ones (babA,
Fig. 10 Protein-protein interactions. Stronger associations are represented by blue thick lines. The predicted functional partners for our query
protein adeK are a family of adeA, adeJ, adeI, multidrug ABC transporter and multidrug efflux pump. Pili assembly chaperone and P Pilus
assembly protein, which are responsible for pili assembly have interaction with a fimbrial protein. Outer membrane protein OmpA interacts with
TolB (involved in TonB-independent uptake of colicins) and peptidoglycan associated lipoprotein. ponA (penicillin binding protein 1a) and general
secretion pathway protein D interacts with a group of Type IV pili proteins, including Tfp pilus assembly protein PilP, type IV fimbrial biogenesis
protein PilO and type IV pilus assembly protein PilM. These interactions show that the bacteria possess flagellum independent surface associated
motility, and ponA and general secretion pathway protein D assist the type IV pili multi-protein in exhibiting this property in A. baumannii. These
associations aid bacteria to adhere to biotic and abiotic surfaces and facilitate in enhanced virulence, colonization and subsequently to disease
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sabA, fecA and omp16) [114] against this Gram negative
pathogen.
Discussion
A. baumannii is an emerging MDR pathogen which is
responsible for 2–10 % of all Gram negative hospital infec-
tions [115]. The devastating healthcare and economic im-
pact of A. baumannii infections in hospitals worldwide
emphasize on the imperative need to exploit new ap-
proaches to confront the said pathogen. We have
employed the pan-genomics and reverse vaccinology ap-
proaches which have revolutionized the understanding
and tackling bacteria over the recent years. In this study,
30 complete genomes of A. baumannii were analyzed
within the framework of pan-genomics, comparative gen-
omics and proteomics. Previously, A. baumannii com-
parative studies employed varying sample sizes to study
the pathogen genomics. Sahl et al. executed pan-genome
analysis of six complete genomes [116]; Di Nocera et al.
compared seven strains responsible for nosocomial out-
breaks in Mediterranean hospitals [117]. A wider and
comprehensive analysis based on all completely sequenced
genomes would provide a better framework for compari-
son than few organisms. This study showed the subse-
quent increase in pan-genome size with the addition of
new genomes which is suggestive of an open pan-genome
in A. baumannii and emphasizes on the presence of gene
acquisition and loss events in the evolution, adaptation
and persistence of this human pathogen [118]. The pan-
genome comprised of 7,606 coding sequences, of which
2,445 represent core and 5,161 were dispensable genome.
The pan-genome appeared to be remarkably large because
of presence of expansive pool of dispensable genes. The
diverse pan-genome is suggestive of frequent horizontal
gene transfer events [119]. The evolution of pan-genome
is largely affected by the process of gene conservation and
transfer. Various studies have debated on the large and
open pan-genome of A. baumannii [120, 121]. Few com-
parative genomic studies targeted the pan-genome of A.
baumannii and subsequently the core genes have explored
1,455 and 2,688 coding sequences depending on the num-
ber and identity of strains analysis [82, 118, 122]. The
open pan-genome suggests that the said pathogen has the
remarkable propensity for gene gain and gene loss, which
could help in its survival in diverse ecological niches, and
could evolve with enhanced pathogenicity [118].
The A. baumannii strains have been classified based
upon their clonal lineage to get better insights into epi-
demiology of this human pathogen [123]. The rationale
for exploring the clonal lineage and sequence typing fa-
cilitate in characterization of multidrug resistance
phenotype among various strains. Secondly, these clonal
studies assist in understanding the phenomenon of hori-
zontal gene transfer in the A. baumannii strains,
persuading in adaptation of this bacterium in diverse
ecological environments [19]. For instance, A. bauman-
nii AYE belonging to clonal complex I had acquired an
86-kb resistance island (AbaR) under the selective pres-
sure of broad spectrum antibiotics. AbaR is absent from
first sequenced A. baumannii ATCC 17978, isolated be-
fore the development of new generation antibiotics
[118]. The phylogenetic analysis based on 16srRNA se-
quences and on shared gene families showed that strains
belonging to same clonal lineages are closely related to
each other and they exhibit strong homology in their
proteome. The comprehensive whole proteome pair wise
comparison led us to similar findings. The presence of
common proteins among the strains convincingly sup-
ports that peptide vaccines can be efficiently developed
against A. baumannii [124].
The success of A. baumannii can be attributed to its re-
markable ability to harbor significant virulence factors as
part of its core conserved genome; aiding it to adhere,
colonize, form biofilms and escape antibiotics [125]. Exist-
ence of certain virulence factors in the core genome like
peroxiredoxin, high temperature protein G (HtpG), thiore-
doxin disulfide reductase (TrxB), superoxide dismutase,
chaperone protein DnaJ, support A. baumannii to survive
in stressful conditions. Furthermore, it was observed that
there is spread of similar virulence factors and among a sin-
gle clonal complex, thus aiding in the persistence of this
bacterium in a particular geographical location. The exist-
ence and expansion of homogenous clonal lineages, whose
main difference from the non-clonal A. baumannii appears
to be their antimicrobial resistance, credibly suggests that
there is horizontal acquisition of resistance genes from
other nosocomial pathogens [126]. Virulence factors com-
prised of 12 % of the core genome, which suggests that ac-
quisition or existence of virulence factors is not likely a
predominant factor in the recent nosocomial spread of A.
baumannii clones. Other factors should be considered for
the evolution of this pathogen as global superbug. One pos-
sibility is its innate notorious ability to adapt to its adverse
environmental conditions and nosocomial settings. Another
likelihood could be the differential regulation of conserved
set of virulence genes according to the strain [127]. Syner-
gistic effect of multiple genes or polymorphic differences in
shared virulence genes may play a part in diverse virulence
potential of said pathogen [86].
Due to its remarkable ability to develop antimicrobial
resistance, vaccination is considered a reliable alternative
strategy to prevent infections caused by this drug resistant
bacterium [128]. Few conventional approaches have previ-
ously been used to identify potential vaccine candidates.
Outer membrane and whole cell preparations have been
employed in murine models of sepsis and generated active
and passive immune response [129, 130]. But endotoxin
contamination limited these conventional approaches to
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be developed or used in humans. In contrast, development
of subunit peptide vaccines based on in silico reverse vac-
cinology (RV) approaches offer a feasible alternative, as
these can induce efficient immunogenic response and can
be obtained on a large scale [9]. The use of sequence
based approaches ensures the reliable vaccine candidates,
and is strengthened by the employment of various search
tools and filtering steps [131]. In this study, we have
adopted combinatory approach to identify putative vac-
cine candidates against A. baumannii, and we deduce that
this will be more efficient than data obtained from each
method as a standalone technique. Core protein of all the
30 included strains was considered as it would lead to a
more representative and conserved set of targets. The
strains employed covered representatives from the inter-
national A. baumannii clones currently circulating the
globe. Appropriate location of proteins aid in effective rec-
ognition by MHC molecules and in inducing strong im-
munogenic responses [132]. Among the core proteins, we
have selected those proteins which are on cell surface or
in periplasmic or extracellular space. Parameters of essen-
tiality, virulent, non-host homologs, molecular weight and
trans-membrane helices were summed up and thirteen
core proteins have been found out to be potential vaccine
candidates. This included OmpA which have been previ-
ously examined as vaccine candidate against A. bauman-
nii. OmpA is an important virulence factor in the
pathogenesis of A. baumannii infections [133]. OmpA is
highly conserved among the clinical strains, but share
minimal homology to human proteome [134]. In vitro
studies have shown that it induces phenotypic maturation
of dendritic cells (DC) and promote Th1 immune re-
sponses, and in vivo murine melanoma models, it stimu-
lates maturation of murine splenic DCs and associate with
enhanced surface expression of co-stimulatory molecules
CD 80 and CD 86 and MHC class I and II molecules of
dendritic cells [135]. In another in vivo testing of OmpA
antigen with aluminium hydroxide adjuvant in diabetic
mice resulted in production of high anti-OmpA antibody
titers and also improved survival of mice following intra-
venous infection with A. baumannii [134, 136]. In another
study, OmpA was found to induce little protection in a
mouse model of A. baumannii pneumonia infection [137].
The difference in these observations could be due to route
of challenge, immunization strategies, OmpA refolding,
and animal models. Besides, OmpA few other antigens
have been identified which could elicit immune response.
By combining in silico comparative genome analysis with
proteomic approaches, Moriel et al. identified 42 surface-
exposed and secreted antigens from A. baumannii that
could be used as potential vaccine targets [138]. Chiang
et al. analyzed 14 complete genomes of A.baumannii and
identified 13 genes from 2752 homologous core genes of
A. baumannii as potential vaccine candidate antigens.
Peptidoglycan associated lipoprotein identified from our
analysis of 30 complete genomes was also identified as po-
tential antigenic candidate by Chiang et al. [139].
It is analyzed in this study that two of the prioritized
core proteins PonA and general secretion pathway protein
D interact with three TFP proteins naming Tfp pilus as-
sembly protein PilP, type 4 fimbrial biogenesis protein
PilO and type IV pilus assembly protein PilM. These three
TFP proteins are bacterial surface appendages and partici-
pate in natural transformation, twitching motility and ad-
herence of bacteria [140]. This suggests that bacteria
possess significant surface core proteins which assist with
TFP proteins to help bacteria to exhibit motility. This
property helps bacteria to adhere to biotic and abiotic sur-
faces and facilitate in virulence, colonization and subse-
quently cause the infection. Peleg et al. recently studied
the virulence behavior of six A. baumannii strains and
interestingly found presence of TFP proteins in its core
proteome, facilitating in survival of bacteria in divers eco-
logical niches [141]. Recently, Eijekelkamp et al. observed
that all the A. baumannii strains that belong to clonal
lineage I were capable of twitching motility, indicating that
they may produce TFP [142]. AdeK, another core vaccine
target in this study, belongs to AdeIJK resistance nodula-
tion cell division (RND) family efflux pump reported in A.
baumannii [143]. This tripartite pump comprised of AdeI,
AdeJ and AdeK genes which encode membrane fusion
protein, transporter and outer membrane component of
the pump, respectively [143]. This type of pumps contrib-
utes to resistance to β -lactams, chloramphenicol, tetra-
cycline, erythromycin, flouroquinolones, fusidic acid,
trimethoprim, rifampin, pyronine and sodium dodecyl
sulphate [144]. Presence of AdeK in core proteome of
thirty A. baumannii strains suggests that bacteria have ac-
quired robust mechanisms in its core genome to exhibit
resistance to almost all major antibiotics. PPI showed that
this core protein interacts with its accomplices (AdeI,
AdeJ, AdeK) and with multidrug transporter proteins en-
abling it to successfully efflux antibiotics, leading to its
survival in hospital settings. TonB dependent siderophore
receptor found out as an essential core protein in our
study. Cells growing in aerobic conditions have adapted
complex strategies to overcome scarcity of iron, an essen-
tial element. Outer membrane protein localized com-
plexes like TonB proteins bind with iron chelates at the
cell surface and promote their uptake [145]. We have ob-
served that A. baumannii correlates with FhuE receptor
for maximal transport efficiency of iron, coprogen and
ferric-rhodotorulic acid across the membrane [104].
Fajardo Bonin et al. used human sera from A. baumannii
infected patients to screen against A. baumannii outer
membrane proteins and identified six immune-reactive
proteins including ferric siderophore receptor protein,
OmpA, Omp34kDa, OprC, OprB-like, OXA-23 [146,
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147]. Further in vivo studies are required to validate the
immunogenicity of these candidates.
The conserved regions within a protein are considered to
evolve slowly. These regions usually considered vital for
function and believed to be associated with lower variability
and are highly conserved among different strains, addition-
ally, these regions are often represent reliable targets for the
development of epitope-based vaccines [148]. Likewise, the
predicted vaccine candidates containing conserved (100 %)
epitopes such as IQSSGSYEY, YSGDSQLNA might be ef-
fective in providing broad-spectrum protection. The three
epitopes (WGDESNERC, IKEDANLAA and IKLYDSNVN)
showed 80–90 % conservations which is an indication of a
slight variability in parent proteins and hence the rapid evo-
lution the regions. As these epitopes are found with less
than the identity level threshold and should be critically re-
considered as they may suggest the uniqueness of the spe-
cific epitope. As the different strains of A. baumannii in-
cluded in this study belong to different geographical
locations they might have adapted diverse virulence mech-
anism and pathogenesis, such as proteins P pilus assembly
protein, pilus assembly chaperone and FhuE receptor.
These proteins and associated epitopes may be effectively
considered for designing strain-specific vaccines.
The pipeline is validated by predicting the potential
vaccine candidates against H. pylori. Studies on large
and small animal models have already been carried out
to demonstrate the efficacy of vacA and cagA against H.
pylori through vaccination [149, 150]. In addition, prom-
ising findings were also observed in preclinical trials as a
result of vaccination, which includes the induction of T-
cell mediated immunity (local gastric Th1 and Th17 re-
sponses) [151]. Two recently conducted phase I clinical
trials in human volunteers based on three recombinant
antigens (cagA, vacA and NAP) induced T-cell responses
[152]. Our computational pipeline successfully identified
already known immunogenic targets (vacA) [149, 153]
and along with novel ones (babA, sabA, fecA and
omp16) [114] against the H. pylori. This serves as posi-
tive control for our proposed pipeline to identify poten-
tial vaccine targets in H. pylori. Thus, we are confident
about the predictions by employed methodology and the
identified vaccine candidates against A. baumannii and
hence the functionalities of the proposed pipeline.
All the theoretical approaches have advantages and
limitations in general, regarding the methodology
adopted in this manuscript; a possible challenge is the
predicted prioritized protein “PonA (PBP1a)” which is
found to be attached with the cytoplasmic membrane
and hence, may not be effectively generate immune re-
sponse (antibodies). Basically, parameters were set to in-
clude all the outer membrane proteins, extracellular and
periplasmic proteins. Among the predicted proteins,
ponA is found out as extracellular protein by the sub-
cellular localization program “PsortB”. This could be
considered as a limitation of the tool itself, not with the
overall pipeline; therefore it is suggested that the re-
searcher should cross-check the findings with other sub-
cellular localization tools such as Cello, MetaLocGramN
etc. [93, 154]. In this manuscript, a universal pipeline is
proposed which could be applied on both the Gram
positive and Gram negative bacteria in general; however,
it is strongly suggested that the parameters may be care-
fully monitored and adjusted while dealing with Gram
negative bacteria due to compositions of cell wall.
Similarly, the peptidoglycan associated lipoprotein
which is anchored in the outer membrane of Gram
negative bacteria through an N-terminal hydrophobic
domain and interacts with the cell wall peptidoglycan by
C-terminal OmpA-like domain. This protein is classified
as an outer membrane by the program (PsortB)
employed for subcellular localization and validated by
another program (Cello) as well. Previously, the peptido-
glycan associated lipoproteins have been reported to be
potential vaccine candidates in few Gram negative bac-
teria e.g., Haemophilus influenzae, Haemophilus ducreyi,
Legionella pneumophila and Campylobacter jejuni.
Quite recently, in a study conducted by Huang et al. in
2016, Omp22 from A. baumannii efficiently elicited high
titers of specific IgG in mice [155]. Domain analysis re-
vealed that Omp22 might be an “outer membrane
protein-related peptidoglycan-associated (lipo) protein”
[155]. This in vivo study further strengthens the role of
this protein in generating substantial immune response
against A. baumannii.
Considerable progresses have been made recently in the
development of an effective vaccine to combat infections
due to MDR A. baumannii. Several experimental vaccines
have been evaluated and induced satisfactory antibody re-
sponses [156]. However, substantial methodical challenges
remain in the development of safe and effective vaccines
for A. baumannii. The role of antibodies in vaccine
induced protection has already been elucidated in
immunization studies but thorough advanced specifics
like antibody mediated opsonization, bactericidal studies,
mucosal IgA antibody response, T cell response need fur-
ther research. These understandings will likely to acceler-
ate the vaccine development. Based upon the rapid course
of A. baumannii infection, it is imperative to have an effi-
cient vaccine which can control bacterial replication at an
early stage of disease. Compared to other pathogens, rela-
tively smaller numbers of antigen candidates have
currently been identified for A. baumannii vaccines. How-
ever, recent enhanced exploration of pan-genomics, viru-
lence factors, antibiotic resistant islands, pathogenicity
islands of A. baumannii are likely to expedite the identifi-
cation and development of effective vaccine candidate
against said pathogen. Large scale studies like ours
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encompassing the pan-genomics, comparative genomics,
reverse vaccinology, immunoproteomics would contribute
to rational design of vaccine against A. baumannii.
Conclusion
The study, based upon combinatorial approach of pan-
genomics, core genomics, proteomics and reverse vaccinol-
ogy led us to find out potential vaccine candidates against
A. baumannii. The comprehensive analysis of all the com-
pletely sequenced genomes revealed thirteen putative anti-
gens naming P pilus assembly protein, pili assembly
chaperone, AdeK, PonA, OmpA, general secretion pathway
protein D, FhuE receptor, Type VI secretion system OmpA/
MotB, TonB dependent siderophore receptor, general
secretion pathway protein D, outer membrane protein, pep-
tidoglycan associated lipoprotein and peptidyl-prolyl cis-
trans isomerase;which could elicit substantial immune
response. The integration of computational vaccinology
strategies would facilitate in tackling the rapid dissemin-
ation of resistant A.baumannii strains. Future work is sug-
gested towards the characterization of the candidate
proteins and immunology followed by evaluation in animal
models.
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